The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Open accessAbstract
The shared role of amyloid-β (Aβ) deposition in cerebral amyloid angiopathy (CAA) and Alzheimer disease (AD) is arguably the clearest instance of crosstalk between neurodegenerative and cerebrovascular processes. The pathogenic pathways of CAA and AD intersect at the levels of Aβ generation, its circulation within the interstitial fluid and perivascular drainage pathways and its brain clearance, but diverge in their mechanisms of brain injury and disease presentation. Here, we review the evidence for and the pathogenic implications of interactions between CAA and AD. Both pathologies seem to be driven by impaired Aβ clearance, creating conditions for a self-reinforcing cycle of increased vascular Aβ, reduced perivascular clearance and further CAA and AD progression. Despite the close relationship between vascular and plaque Aβ deposition, several factors favour one or the other, such as the carboxy-terminal site of the peptide and specific co-deposited proteins. Amyloid-related imaging abnormalities that have been seen in trials of anti-Aβ immunotherapy are another probable intersection between CAA and AD, representing overload of perivascular clearance pathways and the effects of removing Aβ from CAA-positive vessels. The intersections between CAA and AD point to a crucial role for improving vascular function in the treatment of both diseases and indicate the next steps necessary for identifying therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, brains from COVID patients also show ischemic and hemorrhagic lesions, as well as microglial activation [79], which can be seen in many AD patients with cerebral amyloid angiopathy [80].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Inflammation does, however, not seem to be a major component in CAA-related microhemorrhage or microinfarction [38], with the exception of a rare clinical subtype: CAA-related inflammation [6].”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [6]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“Chronic inflammation‐induced disruption of the BBB is an early biomarker of human cognitive dysfunction and often leads to dementia, 113 and both Aβ deposits and tau pathology aggravate vascular damage. 114 , 115”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [115]
In the citing paper
“There is overwhelming evidence for cerebrovascular alterations in AD pathology and amyloid-β deposition around leptomeningeal vessels is a hall mark of cerebral amyloid angiopathy, occurring in almost all AD patients”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Greenberg et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Self-citation
Cited by
Sorted by citations
Items 801–900 of 954
Chikh, K., Burel, J., Nikiema, A., Bulteau, H., Maltête, D., Wallon, D., Gérardin, E., Aboukaïs, R., Gaberel, T., Derrey, S., et al. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.09.006
Kasai, T., Akazawa, K., Kitani‐Morii, F., Naeshiro, Y., Suo, H., Fujino, Y., Yoshida, M., Shimizu, T., Sakai, K., Watanabe, K., et al. (2026) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000552381
Mural Cells, Microvessels, and Alzheimer’s Disease
Bonney, S. K., Nielson, C. D., & Shih, A. Y. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_15
PCSK9 and High-Fat Diet Synergistically Induce Neurovascular Dysfunction and NeuroinflammationPreprint
Zhang, M., Letian, A., Mohl, G. A., Kroke, B., Arkelius, K., Clelland, C. D., Goldberg, E. L., & Singhal, N. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.29.685380
Zachara, R., de Carrillo, D. G., Właszczuk, A., Gorzkowska, A., Mazur, W., & Jędrzejowska–Szypułka, H. (2025) · Neurology International · doi:10.3390/neurolint17110180
Kawakami, N., Satoh, S.-Y., & Li, Z. (2022) · Bulletin of pioneering researches of medical and clinical science · doi:10.51847/w9sthzgjvw
Lope‐Piedrafita, S., Serra-Mir, G., Melón, P., Bonaterra‐Pastra, A., Hernández‐Guillamón, M., & Villegas, S. (2025) · Biomolecules · doi:10.3390/biom15111602 · Cited by 1
Maki, H., Kondo, Y., Minamiguchi, S., Kojima, D., Ohba, S., Adachi, S., Watanabe, H., & Inoue, M. (2025) · Cureus · doi:10.7759/cureus.97214
Neurological aging and neurodegenerative disease in humans and great apes
Edler, M. K., Hearn, C. J., Guevara, E. E., Mhatre‐Winters, I., Varghese, M., Freire‐Cobo, C., Sherwood, C. C., Richardson, J. R., Raghanti, M. A., & Hof, P. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27380-3.00074-9
Potential Role of Quercetin and Its Derivatives in Treatment of Cognitive Dysfunction Disorders
Song, L., Hu, L., Zhou, Q., Lu, J. G., Zhang, S.-L., & Zhou, H. (2025) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-025-3951-5
Jiang, J., Zhang, H., Ba, M., Qiao, S., Weng, C., Yao, X., Ling, R., & Kang, T. (2025) · International Conference on Intelligent Computing and Data Analysis · doi:10.1145/3772726.3772862
Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22618616
Kim, S. H., Ahn, J. H., Yang, H., Lee, P., Koh, G. Y., & Jeong, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13199131
Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22618622
Kim, S. H., Ahn, J. H., Yang, H., Lee, P., Koh, G. Y., & Jeong, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13199128
Chen, S., Guo, D., Zhu, Y., Xiao, S., Xie, J., Zhang, Z., Hu, Y., Huang, J., Ma, X., Ning, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397542
Chen, S., Guo, D., Zhu, Y., Xiao, S., Xie, J., Zhang, Z., Hu, Y., Huang, J., Ma, X., Ning, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25397692
Yang, Y., Murzin, A. G., Peak-Chew, S., Franco, C., Garringer, H. J., Newell, K. L., Ghetti, B. F., Goedert, M., & Scheres, S. H. W. (2024) · Figshare · doi:10.6084/m9.figshare.26649156
Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22618631
Rasing, I., Voigt, S., Koemans, E. A., de Kort, A. M., van Harten, T. W., van Etten, E. S., van Zwet, E. W., Stoops, E., François, C., Kuiperij, H. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25678502
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633332
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633335
Uekawa, K., Hattori, Y., Ahn, S. J., Seo, J., Casey, N., Anfray, A., Zhou, P., Luo, W., Anrather, J., Park, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24240134
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633311
Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22618628
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633317
Chen, S., Guo, D., Zhu, Y., Xiao, S., Xie, J., Zhang, Z., Hu, Y., Huang, J., Ma, X., Ning, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692306
Bernal, J., Schreiber, S., Menze, I., Ostendorf, A., Pfister, M., Geisendörfer, J., Nemali, A., Maaß, A., Yakupov, R., Peters, O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26591507
Wang, X., Xie, Y., Fan, X., Wu, X., Wang, D., & Zhu, L. (2024) · Figshare · doi:10.6084/m9.figshare.26728936
Yang, Y., Murzin, A. G., Peak-Chew, S., Franco, C., Garringer, H. J., Newell, K. L., Ghetti, B. F., Goedert, M., & Scheres, S. H. W. (2024) · Figshare · doi:10.6084/m9.figshare.26649159
Zellner, A., Müller, S. A., Lindner, B., Beaufort, N., Rozemüller, A. J. M., Arzberger, T., Gassen, N. C., Lichtenthaler, S. F., Kuster, B., Haffner, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029563
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633329
Kim, S. H., Ahn, J. H., Yang, H., Lee, P., Koh, G. Y., & Jeong, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13199125
Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22618634
Kim, S. H., Ahn, J. H., Yang, H., Lee, P., Koh, G. Y., & Jeong, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13199122
Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22618619
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633314
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633326
Bonaterra‐Pastra, A., Solé, M., Lope‐Piedrafita, S., Lucas-Parra, M., Castellote, L., Marazuela, P., Pancorbo, O., Rodríguez‐Luna, D., & Hernández‐Guillamón, M. (2024) · Figshare · doi:10.6084/m9.figshare.26391677
Vervuurt, M., Kuiperij, H. B., de Kort, A. M., Kersten, I., Klijn, C. J. M., Schreuder, F. H. B. M., & Verbeek, M. M. (2024) · Figshare · doi:10.6084/m9.figshare.25824651
Wang, X., Xie, Y., Fan, X., Wu, X., Wang, D., & Zhu, L. (2024) · Figshare · doi:10.6084/m9.figshare.26728939
Kim, S. H., Ahn, J. H., Yang, H., Lee, P., Koh, G. Y., & Jeong, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13199134
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16633323
Chen, S., Guo, D., Zhu, Y., Xiao, S., Xie, J., Zhang, Z., Hu, Y., Huang, J., Ma, X., Ning, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26692303
Mechanisms of Dural Involvement in Cerebral Amyloid Angiopathy
Zedde, M., Piazza, F., & Pascarella, R. (2025) · Cells · doi:10.3390/cells15010026
Rare ABCA7 mutations in Alzheimer’s disease and cerebral amyloid angiopathy pathology
de Craen, E. H. V., Bossaerts, L., Sieben, A. A., den Bossche, T. V., Bjerke, M., Hanseeuw, B. J., Bergmans, B. A., Vandenberghe, R. R., Deyn, P. P. D., Cras, P. P., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.12.010
Sýkora, M., Harmackova, M., Parobková, E., Rusina, R., & Matěj, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1703718
Cerebral amyloid angiopathy: updates on pathophysiology, diagnosis, and management
Willsey, T. R., Faselis, C. J., Ahmed, A., & Sin, M. (2026) · Exploration of neuroscience · doi:10.37349/en.2026.1006121
Systemic Amyloid-β Metabolism in Alzheimer’s Disease
Dong-yu, F., Wang, J., Gu, B. J., Masters, C. L., & Wang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_7
Weglarz, P., Pathak, S., Dhanasekaran, M., Vijayarani, K. R., Ameen, R. S., & Bhupathyraaj, M. (2026) · Nutritional neurosciences · doi:10.1007/978-981-95-5791-2_4
Alzate‐Correa, D., Stranan, J. P., Rincon‐Benavides, M. A., Mazo, N. A., Narváez-Pérez, L. F., Jaramillo-Garrido, S., Nguyen, T., Patel, R., Lawrence, W. R., Diaz‐Starokozheva, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.22.700900
Amyloid extraction from neurodegenerative disease tissues for structural studies
Alhadidy, M. M., Hinton, T. V., Ernst, K. N., & Yang, Y. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.01.032
Expression of matrix metalloproteinases in cerebral amyloid angiopathy-a systematic review
Gu, H., Shi, X., & Zhang, J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1753708
Rare and Rapidly Progressive Syndromes
Vanderbleek, E. N., Weitzner, D. S., & Boscarino, J. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-05880-5_10
Pikus, P., Healey, G. S., Xia, E., Shautidze, G., Siddapureddy, N., Lee, Y., Albanese, C., Rodriguez, O. C., Turner, R. S., & Rebeck, G. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.09.704876
Taweephol, T., Smitasiri, T., Pongpitakmetha, T., Thanprasertsuk, S., & Viswanathan, A. (2026) · Chulalongkorn Medical Journal · doi:10.56808/2673-060x.5589
Vicious circle of amyloid and leptomeningeal macrophages evokes vascular dysfunction in CAAPreprint
Hartantyo, R. Y., Tsuji, T., Hou, L., Saito, R., Yamasaki, A., Kochi, T., Saito, Y., Tada, M., Cheung, D. L., Moorhouse, A. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.12.705483
Fan, Z., Liu, X., Lu, X., Wu, Y., & Zhou, M. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07159-6
Chenghan, M., Zhong, Q., Xiaojie, L., Yao, H., Zhang, T., Zhao, B., Jiangshang, L., & Zhihui, Z. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.17.706258
Stellingwerf, A., Bosveld, D., Jäkel, L., de Kort, A. M., Küsters, B., Klijn, C. J. M., Schreuder, F. H. B. M., Kuiperij, H. B., & Verbeek, M. M. (2026) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70064
van den Berg, M. L., Munting, L. P., Li, H., Yi, I., Bailey, J. J., Richardson, D. S., Zwang, T. J., van Veluw, S. J., & Kozberg, M. G. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261424057
Carey, A. M., Buzhdygan, T. P., & Fossati, S. (2026) · Cells · doi:10.3390/cells15050424
Amyloid β-related angiitis (ABRA) with dural contrast enhancement
Imamura, D., Ishii, J., Hosoki, S., Miyata, M., Hara, S., & Kawamoto, M. (2026) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-002178
Hou, K., Lu, H., Zhang, R., Wang, Y., Xu, G., Long, F., Lu, J., Xing, D. M., Huang, L., Sun, Y., et al. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261433955
Razenkova, V. A., & Korzhevsky, D. E. (2026) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2026.008
Unique Expression and Glycosylation of Amyloid Precursor Protein in Alzheimer’s Disease
Tachida, Y., & Kitazume, S. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-04153-1_4
Abdelouahab, O. B. (2021) · theses.fr (ABES) · doi:10.70675/97f4885fz3f5cz4234zb8e2ze3fa7c4e3d41
Développement d’un test sanguin pour le dépistage de la maladie d’Alzheimer
Torres, F. D. (2022) · theses.fr (ABES) · doi:10.70675/afbb97a5z1636z46abz844czb340616aeda1
Gökçal, E., Becker, J. A., Horn, M. J., Das, A. S., Viswanathan, A., Rosand, J. M., Polimeni, J. R., Sperling, R. A., Johnson, K. A., Greenberg, S. M., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214859
Self-citationRole of extracellular space in neurodegenerative diseases
Estaún‐Panzano, J. (2024) · theses.fr (ABES) · doi:10.70675/98d1d96eza025z406ezba93z33e0820c3cf3
You, M., Tang, C., Liu, L., Chen, D., Wu, Y., & He, D. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100568
Tsai, S., Liew, H., Wang, M.-J., Hung, W.-T., & Huang, H.-Y. (2026) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj-d-25-00173
Salian, V. S., Wang, Z., Curran, G. L., Podulso, J. F., & Kandimalla, K. K. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01565
Luo, Z., Li, H., Wang, T., & Feng, X. H. (2026) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2026.108655
Hemorrhage Pattern and Amyloid Burden in Cerebral Amyloid Angiopathy
Gökçal, E., Becker, J. A., Horn, M. J., Rotschild, O., Das, A. S., Fouks, A. A., Rosand, J. M., Viswanathan, A., Johnson, K. A., Gurol, M. E., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.048858
Self-citationAbnormal Amyloidogenesis Identified in Plasma of Patients with Spinocerebellar Ataxia Type 12
Banerjee, R., Sengupta, S., Rungta, J., Ansari, S., Banerjee, S., Biswas, B., Pal, R., Chattarji, S., Choudhury, S., & Kumar, H. (2026) · The Cerebellum · doi:10.1007/s12311-026-02015-0
Zedde, M., Basso, G., Piazza, F., & Pascarella, R. (2026) · Springer eBooks · doi:10.1007/978-3-032-23618-0_7
APOE Gene Editing as a Therapeutic Target Toward Precision Medicine in AD
Teter, B., Campagna, J. J., Spilman, P., & John, V. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_73
Iatrogenic Cerebral Amyloid Angiopathy
Zedde, M., Kaushik, K., Wermer, M. J. H., Piazza, F., & Pascarella, R. (2026) · Springer eBooks · doi:10.1007/978-3-032-23618-0_13
Li, Z.-J., Yang, Z., Zhao, D., Qiu, Y., Wan, W., Huang, Z.-K., Tian, L., Qi, R., Liu, H., Chen, Y., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71494
Direct heterotypic interactions drive the accelerated co-aggregation of amyloid-β with Medin
Chuanyong, C., Xuewei, D., Xin, Y., Wenqiang, T., Bing, Y., & Kai, Y. A. N. G. (2026) · Acta Physica Sinica · doi:10.7498/aps.75.20260543
Kobayashi, H., Moizumi, A., Maeda, T., Kurita, H., Tokuraku, K., & Kuragano, M. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.115082 · Cited by 1
A perivascular perspective on the immune impacts in cerebral amyloid angiopathy
Eyre, B., & Bonney, S. K. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261454165
Ex vivo comparison of ACU193 and lecanemab reveals binding differences in mouse brain
Grenon, M. B., Cline, E. N., Jerecı̀ć, J., Johnson, E. A., Siemers, E., & Lemere, C. A. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71509
Angiopathie amyloïde cérébrale héréditaire
Grangeon, L., Nicolas, G., & Wallon, D. (2026) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(26)49255-6
Leung, J. M., Rojas, J. C., Chan, B., Du, Z., Du, P., & Sands, L. P. (2026) · NeuroMarkers. · doi:10.1016/j.neumar.2026.100180
Toyokawa, M., Yasuda, K., Kikuya, A., Asada‐Utsugi, M., Hida, M., Nakamura, Y., Yanagida, N., Toda, S., Kaji, S., Kinoshita, Y., et al. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150436
Xing, X., Wang, K., Feng, Y., Wu, C., Jia, L., Li, H., Wen, Z., Tang, Y., Wang, Z., Zhang, X., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1822543
Huang, G., Zhang, Z., & Ding, F. (2026) · Biomacromolecules · doi:10.1021/acs.biomac.6c00811
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
Treatment Using Anti-Amyloid Antibodies for Alzheimer’s Disease
Chatterjee, S., Gayen, S., & Roy, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010012
Untangling the web of APOE, cerebral amyloid angiopathy and Alzheimer’s disease
Banerjee, G., & van Veluw, S. J. (2026) · Brain · doi:10.1093/brain/awag243
Jang, H., Kim, J. S., Hwang, J. W., Jeong, D. W., Ka, J., Kang, D. M., Suh, C. H., Choi, Y., Oh, M., Kim, J. S., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02141-1
Wang, J., Cao, X., & Wan, M. (2026) · Journal of Clinical Investigation · doi:10.1172/jci207273
Metadata
- Authors
- Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Greenberg, Steven M.
- Venue
- Nature Reviews Neurology
- Published
- 2019-12-11
- Volume
- 16
- Issue
- 1
- Pages
- 30-42
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC7268202
- OpenAlex
- W2995183059
- Cited by
- 947
- References
- 232
- Citations by year
- 2026: 146 · 2025: 198 · 2024: 179 · 2023: 154 · 2022: 113 · 2021: 104 · 2020: 52
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG026484)
- National Institute of Neurological Disorders and Stroke (RF1NS110054, R01NS096730, U24NS100591)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- cerebral amyloid angiopathy, Alzheimer's disease, amyloid-beta, amyloid-beta clearance, amyloid-related imaging abnormalities, anti-amyloid immunotherapy, vascular function
- MeSH terms
- Alzheimer Disease, Brain, Humans, Signal Transduction, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
